✦ LIBER ✦

Adverse events in phase-I studies: a report in 1015 healthy volunteers

✍ Scribed by M. Sibille; N. Deigat; A. Janin; S. Kirkesseli; D. Vital Durand

Publisher: Springer
Year: 1998
Tongue: English
Weight: 280 KB
Volume: 54
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s002280050413

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adverse events in phase one studies: a s

Adverse events in phase one studies: a study in 430 healthy volunteers

✍ M. Sibille; N. Deigat; V. Olagnier; D. Vital Durand; R. Levrat 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 445 KB

All the clinical, laboratory and electrocardiographic adverse events detected during 24 Phase I studies in the same unit over a 5 y period are reported here. 430 healthy male volunteers were involved, corresponding to 5488 days of follow-up. The overall incidence of adverse events was 13.5%, with a

A phase I study of monohydroxyethylrutos

A phase I study of monohydroxyethylrutoside in healthy volunteers

✍ Anja M. Willems; Anne M. Bruynzeel; Marc A. Kedde; Cees J. van Groeningen; Aalt 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 311 KB

Laboratory data in healthy volunteers: r

Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in Phase I clinical trials

✍ M. Sibille; N. Deigat; I. Durieu; M. Guillaumont; D. Morel; J. Bienvenu; D. Mass 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 96 KB

Cognitive testing in early phase clinica

Cognitive testing in early phase clinical trials: outcome according to adverse event profile in a Phase I study

✍ Alex Collie; Paul Maruff; Peter J. Snyder; Miss Amanda Darekar; John P. Huggins 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## Background It has been proposed that objective cognitive testing provides additional information to that collected via adverse event (AE) recordings. However, in clinical trials of compounds with potentially negative effects on cognition, the results of cognitive testing may overlap

Critical limits to define a lab adverse

Critical limits to define a lab adverse event during phase I studies: a study in 1134 subjects

✍ M. Sibille; V. Bresson; A. Janin; B. Boutouyrie; J. Rey; D. Vital Durand 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 154 KB

Evaluation of personality as a component

Evaluation of personality as a component of the healthy condition of volunteers participating in phase I studies

✍ D. Berto; S. Milleri; L. Squassante; P. A. Baroldi 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 66 KB